A decongestant is a medication used to relieve nasal congestion in the upper respiratory tract. Nasal congestion is common with colds, sinusitis and allergic rhinitis and results from swelling of blood vessels and tissue lining the nose. Decongestants reduce that swelling and help restore airflow, making breathing easier and improving sinus drainage. For background on causes of nasal congestion see related resources.
How decongestants work
Most decongestants are sympathomimetic agents that stimulate alpha‑adrenergic receptors in nasal blood vessels, causing vasoconstriction and reduced tissue swelling. This effect can be achieved by systemic (oral) drugs or by topical (intranasal) sprays and drops. Relief is usually rapid with topical agents and somewhat slower but longer lasting with oral formulations.
Types and common active ingredients
- Oral decongestants: commonly contain pseudoephedrine or phenylephrine. Pseudoephedrine has long been effective but is subject to legal restrictions in some regions; phenylephrine is widely used as an OTC substitute for active ingredient information.
- Topical decongestants: include oxymetazoline, xylometazoline and other alpha‑agonists delivered as sprays or drops for local action.
- Combination products: decongestants are often combined with antihistamines, analgesics or cough suppressants in multi‑symptom cold medicines.
Uses, effectiveness and examples
Decongestants are used to relieve nasal blockage from colds, sinus infections and allergic reactions, and to improve comfort when congestion interferes with sleep or breathing. Topical sprays typically act within minutes and are useful for short‑term relief. Oral agents may provide more sustained relief but carry systemic effects.
Safety, side effects and regulatory notes
Common side effects include increased blood pressure, palpitations, insomnia and nervousness. Topical products can cause rebound congestion (rhinitis medicamentosa) when used for more than a few days consecutively. People with hypertension, heart disease, thyroid disorders, diabetes or those taking monoamine oxidase inhibitors should consult a clinician before using decongestants. Pseudoephedrine sales are regulated in many countries because it can be diverted to illicit drug manufacture; this has led to increased use of phenylephrine and restrictions on purchase.
When choosing a decongestant consider the route (topical versus oral), underlying medical conditions and duration of use. For persistent or severe symptoms, medical evaluation is recommended to identify underlying causes and appropriate therapies.